Lower riskDrug recall · FDA · Published September 15, 2022
RemedyRepack Lisinopril 10mg Tablets Recall: Foreign Metal Piece Hazard
RemedyRepack recalls 10mg Lisinopril tablets with a metal piece in one tablet. Stop using if you have the specific lot numbers listed. No remedy provided in official notice.
“RemedyRepack Lisinopril 10mg Tablets Recall: Foreign Metal Piece Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/34323-remedyrepack-lisinopril-10mg-tablets-recall-foreign-metal-piece-hazard. Based on FDA recall #D-1538-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1538-2022%22&limit=1).
The FDA announced on Sept. 15, 2022, that RemedyRepack Inc. is recalling Lisinopril 10 mg tablets due to the presence of a foreign metal piece embedded in one tablet. Owners should contact the company for a refund.
The recall is due to the presence of foreign material, specifically a metal piece, embedded in one tablet. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show RemedyRePack Inc. has 35 other recalls on record since Feb. 18, 2015. Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (June 26, 2026), Guardian Drug Family Wellness Antacid Tablets Recall (May 28, 2026) and Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall (May 28, 2026).
How to tell if you have this one
Check the blister card for the repackaged NDC# 70518-0468-00. Look for lot numbers J0636336-073022 or J0637605-080422. The product expires August 31, 2023.
Brand
RemedyRepack
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check for Metal Piece
Inspect one tablet for a small metal piece. If found, stop using the product immediately.
Where it went and when
Where it was distributed
Distributed in Alaska and Pennsylvania.
Listed by the agency
Not listed
FDA distribution: “Distributed to two direct accounts in PA and AK.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alaska, Pennsylvania.
Recall timeline
FDA terminated this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1538-2022 (September 15, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1538-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.